The 2 analysts offering 12-month price forecasts for Aytu Biopharma Inc have a median target of 17.50, with a high estimate of 24.00 and a low estimate of 11.00. The median estimate represents a +491.22% increase from the last price of 2.96.
The current consensus among 2 polled investment analysts is to Buy stock in Aytu Biopharma Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.41
Reporting Date Sep 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.